taurocyamine

11/01/1988 - "Pretreatment with guanidinoethane sulfonate, a competitive antagonist for beta-amino acid transport, as a 1% drinking solution for ten days led to a significant reduction in brain-cell dehydration. "

01/01/1985 - "MY-103, at doses up to 300 mg/kg, was ineffective against guanidinoethane sulfonate-induced seizures. "
01/01/1985 - "Taltrimide had a greater potency against maximal as compared to minimal seizures, and, at 150 mg/kg, it completely suppressed clonic and myoclonic seizures induced by intracerebroventricular injections of guanidinoethane sulfonate (9.2 ?mol) in rats. "
12/01/1987 - "The susceptibility of rats made deficient of taurine by treatment with guanidinoethane sulfonate (GES), to seizures induced by 4-aminopyridine was examined. "
04/02/1985 - "However, treatment with guanidinoethane sulfonate lessened the antiepileptic actions of phenobarbital and phenytoin on electroshock seizures. "
01/01/1985 - "On the other hand, the antiepileptic potency of phenobarbital and phenytoin against tonic convulsions of maximal electroshock seizures in mice was significantly lessened by chronic administration of guanidinoethane sulfonate. "

09/01/1999 - "Plasma levels of taurocyamine, guanidinosuccinic acid, alpha-N-acetyl-L-arginine, creatine, guanidinobutyric acid, guanidine, and methylguanidine were significantly increased in patients with chronic renal failure with or without hemodialysis. "

12/01/1986 - "Ten rabbits were treated daily with taurine (100 mg/kg by mouth) and eight with guanidinoethyl sulfonate (GES) (100 mg/kg by mouth) immediately after induction of aortic regurgitation. "